Differential Antiviral Activity of Two TIBO Derivatives Against the Human Immunodeficiency and Murine Leukemia Viruses Alone and in Combination with Other Anti-HIV Agents

作者: ROBERT W. BUCKHEIT , JULIE GERMANY-DECKER , MELINDA G. HOLLINGSHEAD , LOIS B. ALLEN , WILLIAM M. SHANNON

DOI: 10.1089/AID.1993.9.1097

关键词: Viral diseaseCell cultureVirusReverse transcriptaseRetrovirusMurine leukemia virusBiologyLeukemiaVirologyCell killing

摘要: R82913 and R86183, two derivatives of tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepm-2(1H)-thione (TIBO), were found to potently selectively inhibit the replication cell killing effects a panel biologically diverse laboratory clinical strains HIV-1. The compounds exhibited significant activity in all human lines tested, as well fresh peripheral blood lymphocytes macrophages. One these (R82913) was significantly murine retrovirus (Rauscher leukemia virus) both UV-XC plaque formation virus yield reduction assays. despite differing from only positioning single chlorine molecule, not active against but 10-fold more potent inhibiting HIV-1 replication. Combination antiviral assays with other reverse transcriptase inhibitors, including AZT, ddC, carbovir, yielded synergistic anti-HIV TIBO derivatives. Additive slig...

参考文章(38)
R. Gallo, S. Salahuddin, M Popovic, G. Shearer, M Kaplan, B. Haynes, T. Palker, R Redfield, J Oleske, B Safai, al. et, Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS Science. ,vol. 224, pp. 500- 503 ,(1984) , 10.1126/SCIENCE.6200936
Owen S. Weislow, Rebecca Kiser, Donald L. Fine, John Bader, Robert H. Shoemaker, Michael R. Boyd, New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity Journal of the National Cancer Institute. ,vol. 81, pp. 577- 586 ,(1989) , 10.1093/JNCI/81.8.577
F Barre-Sinoussi, J. Chermann, F Rey, M. Nugeyre, S Chamaret, J Gruest, C Dauguet, C Axler-Blin, F Vezinet-Brun, C Rouzioux, W Rozenbaum, L Montagnier, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. ,vol. 220, pp. 868- 871 ,(1983) , 10.1126/SCIENCE.6189183
P. L. Nara, P. J. Fischinger, Quantitative infectivity assay for HIV-1 and -2 Nature. ,vol. 332, pp. 469- 470 ,(1988) , 10.1038/332469A0
Janice M. Klunder, Karl D. Hargrave, MaryAnn West, Ernest Cullen, Kollol Pal, Mark L. Behnke, Suresh R. Kapadia, Daniel W. McNeil, Joe C. Wu, Grace C. Chow, Julian Adams, Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinones. Journal of Medicinal Chemistry. ,vol. 35, pp. 1887- 1897 ,(1992) , 10.1021/JM00088A027
Miles W. Cloyd, Barbara E. Moore, Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates Virology. ,vol. 174, pp. 103- 116 ,(1990) , 10.1016/0042-6822(90)90059-Z
PETER M. GROB, JOE C. WU, KENNETH A. COHEN, RICHARD H. INGRAHAM, CHENG-KON SHIH, KARL D. HARGRAVE, TARI L. MCTAGUE, VINCENT J. MERLUZZI, Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug. AIDS Research and Human Retroviruses. ,vol. 8, pp. 145- 152 ,(1992) , 10.1089/AID.1992.8.145